Insufficient scRNA-seq data for expression of TMEM86B at single-cell level.
Insufficient scRNA-seq data for expression of TMEM86B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 1593.76 | 226 / 226 | 99% | 26.25 | 401 / 406 |
| uterus | 100% | 443.46 | 170 / 170 | 99% | 4.65 | 453 / 459 |
| adrenal gland | 100% | 693.36 | 258 / 258 | 97% | 4.98 | 223 / 230 |
| thymus | 100% | 762.46 | 653 / 653 | 95% | 4.25 | 576 / 605 |
| brain | 99% | 622.27 | 2619 / 2642 | 95% | 2.83 | 667 / 705 |
| bladder | 100% | 378.62 | 21 / 21 | 91% | 3.82 | 460 / 504 |
| skin | 98% | 366.04 | 1771 / 1809 | 92% | 2.81 | 434 / 472 |
| esophagus | 100% | 401.46 | 1442 / 1445 | 87% | 2.77 | 160 / 183 |
| pancreas | 91% | 208.56 | 300 / 328 | 96% | 5.47 | 170 / 178 |
| prostate | 100% | 632.40 | 245 / 245 | 86% | 2.03 | 430 / 502 |
| intestine | 100% | 489.46 | 966 / 966 | 84% | 2.26 | 443 / 527 |
| lung | 99% | 444.75 | 574 / 578 | 84% | 2.46 | 973 / 1155 |
| ovary | 100% | 365.22 | 180 / 180 | 83% | 2.07 | 359 / 430 |
| stomach | 100% | 852.50 | 359 / 359 | 83% | 2.31 | 236 / 286 |
| kidney | 100% | 456.25 | 89 / 89 | 81% | 2.27 | 729 / 901 |
| breast | 100% | 356.70 | 459 / 459 | 76% | 1.84 | 853 / 1118 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 7.76 | 29 / 29 |
| peripheral blood | 100% | 1048.90 | 929 / 929 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1282.61 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 3.52 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.25 | 1 / 1 |
| adipose | 99% | 332.66 | 1197 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 98% | 261.39 | 1312 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 94% | 1.95 | 75 / 80 |
| heart | 83% | 157.70 | 713 / 861 | 0% | 0 | 0 / 0 |
| muscle | 78% | 132.08 | 626 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0036151 | Biological process | phosphatidylcholine acyl-chain remodeling |
| GO_0046485 | Biological process | ether lipid metabolic process |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0016020 | Cellular component | membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0016803 | Molecular function | ether hydrolase activity |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0047408 | Molecular function | alkenylglycerophosphocholine hydrolase activity |
| GO_0047826 | Molecular function | D-lysine 5,6-aminomutase activity |
| Gene name | TMEM86B |
| Protein name | Lysoplasmalogenase TMEM86B (EC 3.3.2.2) (Transmembrane protein 86B) |
| Synonyms | |
| Description | FUNCTION: Catalyzes the hydrolysis of the vinyl ether bond of choline or ethanolamine lysoplasmalogens, forming fatty aldehyde and glycerophosphocholine or glycerophosphoethanolamine, respectively and is specific for the sn-2-deacylated (lyso) form of plasmalogen. . |
| Accessions | ENST00000327042.5 Q8N661 |